Join us for an in person support group meeting hosted by Julie, our Arizona Support Group Leader! The meeting will take place at Beyond Bread on 3026 N Campbell Ave in Tucson. If you are an individual diagnosed or a care partner for someone with ADEM, AFM, MOGAD, NMOSD, ON, or TM, we invite you to join us.
Come connect with others and discuss what it’s like living with a rare neuroimmune disorder. Ask questions, share your stories, or just listen – everyone is welcome. If you’d like to attend, please email Julie at [email protected].
COVID-19 Considerations
COVID-19 represents a real and significant risk to our community. If you or anyone in your household is experiencing symptoms or has tested positive we ask that you stay home. If you develop symptoms following the event, please notify us at [email protected]. Please be advised, COVID-19 risks will not be completely eliminated. Even with every intention to minimize risks, SRNA realizes that every attendee must balance these issues and make their own decision regarding risks. On behalf of all in attendance, thank you for your understanding and cooperation.
SRNA 2024 education and support programs are supported by donations from our community and in part through grants from
Amgen Rare Disease is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. They apply scientific expertise and courage to bring clinically meaningful therapies to patients. Amgen Rare Disease believes science and compassion must work together to transform lives.
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal is to deliver medical breakthroughs where none currently exist, and they are committed to ensuring that patient perspective and community engagement is always at the forefront of their work.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit https://www.gene.com.
* All educational content and programs are solely developed by the SRNA staff, members of the scientific board and approved by Board of Directors.
